Where the Companies are Headed: Complementary Research on WaferGen, Xcerra, AAR Corp., Accuride and Advanced Drainage Systems

NEW YORK, December 29, 2014 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including WaferGen (NASDAQ: WGBS), Xcerra (NASDAQ: XCRA), AAR Corp. (NYSE: AIR), Accuride (NYSE: ACW), and Advanced Drainage Systems (NYSE: WMS). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

WGBS Research Report: ( http://get.analystsreview.com/pdf/?c=WaferGen&d =29-Dec-2014&s=WGBS ),

XCRA Research Report: ( http://get.analystsreview.com/pdf/?c=Xcerra&d=29-Dec-2014&s=XCRA ),

AIR Research Report: ( http://get.analystsreview.com/pdf/?c=AAR%20Corp.&d=29-Dec-2014&s=AIR ),

ACW Research Report: ( http://get.analystsreview.com/pdf/?c=Accuride&d=29-Dec-2014&s=ACW ),

WMS Research Report: ( http://get.analystsreview.com/pdf/?c=Advanced%20Drainage%20Systems&d=29-Dec-2014&s=WMS ).

============

--

Analyst Update: Product Update, Financial Results, Agreements and Follow-on Offering

Reviewed by: Rohit Tuli, CFA®  

The U.S. stock market prolonged its winning streak on Friday, ending the day in green, as positive sentiments continued to buoy the markets after the Christmas holiday. The Dow Jones Industrial Average (DJIA) gained for seven consecutive trading days and ended the session at 18,053.71, up 0.13%, while the S&P 500 moved up 0.33% to 2088.77. The Nasdaq Composite advanced 0.70% and closed at 4,806.86, its highest level since March 2000. The European markets will remain close till Monday. The Asian stocks were mostly higher, as investors played down a slew of Japanese economic reports on inflation, industrial output and the labor market.  The data showed that inflation in Japan was slowing, despite efforts of increasing it; however, the market reaction to the November figures was largely muted.

Admera Health will implement WaferGen Bio-systems, Inc.'s (WaferGen) Seq-Ready, a target enrichment technology for next generation sequencing, as Admera launches PGxOne Plus, an expanded version of their proprietary pharmacogenomics test, PGxOne.

Xcerra Corporation (Xcerra) reported solid first quarter fiscal 2015 result as topline improved 288.1% YoY. The strong performance continued in bottom-line as well, as Xcerra reported net income of $12.1 million or $0.23 per diluted share as compared to net loss of $6.9 million or $0.14 per diluted share in Q1 FY 2014.

AAR Corp.'s Q2 FY 2015 earnings of $0.38 per diluted share were in line with Zacks consensus estimate. However, sales for the quarter (period ended November 30, 2014) declined 9.4% YoY to $490.0 million. Net income came in at $15.2 million as compared to net income of $20.0 million in Q2 FY 2014.

Accuride Corporation (Accuride) has attained a new four-year collective bargaining agreement (CBA) with the International Union, United Automobile, Aerospace and Agricultural Implement Workers of America (UAW), Local 718 which represents 291 hourly associates at Accuride's facility in Rockford, Ill. The new agreement is retrospective to November 18, 2014 and effective through March 25, 2019.

A waiver for a lock-up restriction pertaining to 11,500,000  common shares of Advanced Drainage Systems, Inc.'s (Advanced Drainage Systems) held by ASP ADS Investco, LLC, has been announced by the joint book-running managers and representatives of the underwriters - Barclays Capital Inc. and Deutsche Bank Securities Inc., in the recent public offering of 14,500,000 common shares. The Company informed that the shares may be sold or otherwise disposed of on or after effective date of waiver, December 3, 2014.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED